titulo manto flotante
ES
EN
DE
WELCOME!
According to the Swiss Federal Law on the Medicinal Products Advertising Ordinance (AWV; SR 812.212.5), access to specialized advertising for medical products on the Internet must be protected by a password.
Log In
Register
Forgot your password?
Exellent
Customer
Service
FDA and CE
Certificated
Easy
Installation
International
Shipments
ES
EN
DE
¡IMPORTANTE!
xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx xxxx xxxxx
Procedure
BariGlobe
The decision to use the device is made by a doctor. The device should be used by patients whose body mass index (BMI) is 27-40 kg/m2. Patients with a BMI greater than 40 kg/m2 can be treated with the device in order to prepare for surgery.
The collapsed balloon is installed under intravenous anesthesia and permanent endoscopic control. Before the procedure, an endoscopy should be performed to make sure there are no contraindications: ulcerations, gastric cancer, large hiatal hernia, etc. After that, the balloon is inserted through the mouth and down the esophagus into the stomach. The balloon is filled with 400-700 ml of methylene blue-stained saline. After filling the balloon with saline, a ball is formed. The procedure is very simple and does not usually last more than 15 minutes.
Inside the stomach, the balloon fills its excess volume, so less food is needed to provoke the reaction of the receptors, which signal about the filling of the stomach. Therefore, the patient feels full earlier than usual. Over time, the patient gets into the habit of eating less. Subsequently, the patient adapts to the new eating habits and maintains them after the removal of the balloon.
During the first days after balloon placement, the patient experiences nausea, overfilling of the stomach, and unpleasant sensations in the epigastria. The level of these feelings is individual and depends on the patient. The presence of foreign bodies in the stomach increases the production of gastric acid and irritation of the mucous membrane, therefore special drugs are provided for the prevention of these effects. In general, after 7 to 14 days after balloon placement, the patient does not feel the presence of the balloon and can lead a normal lifestyle.
After approximately 2 months from placement of the basic balloon, the "smaller" additional balloon (350-400 mL volume) available in "ADJUSTABLE BARIGLOBE" and "EXTENDED ADJUSTABLE BARIGLOBE" modifications can be placed to overcome the "plateau" weight loss and maintain the rate of weight loss.
The intragastric balloon is installed temporarily. The maximum time the balloon remains in the patient's stomach is 6 months ("BARIGLOBE" and "BARIGLOBE ADJUSTABLE" modifications) or 12 months ("BARIGLOBE EXTENDED" and "BARIGLOBE ADJUSTABLE EXTENDED" modifications), and the balloon must be removed.
The balloon is removed under general anesthesia and intubation. The balloon is pierced with a special endoscopic needle, deflated, and removed through the mouth with forceps.